Literature DB >> 6490380

The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: treatment rationale.

J F Teichgraeber, A A Clairmont.   

Abstract

One hundred thirty-six surgical cases of squamous cell carcinoma of the oral tongue and floor of the mouth at the Emory University Hospitals were reviewed for the incidence of occult metastases. Thirty-five percent of the T1 T2 lesions of the anterior tongue had occult metastases. The figure was 31.5% for similarly staged lesions of the floor of the mouth. The presence of regional metastases resulted in a 2-year determinate survival rate of 37% and 32% for patients with oral tongue and floor of the mouth lesions, respectively. The poor prognosis in the study for delayed cervical metastases and the high incidence of occult cervical metastases have led the authors to propose a more aggressive therapy for the clinically negative necks in these two sites of squamous cell carcinoma of the oral cavity.

Entities:  

Mesh:

Year:  1984        PMID: 6490380     DOI: 10.1002/hed.2890070105

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  31 in total

1.  Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.

Authors:  Cheng Wang; Xiqiang Liu; Zujian Chen; Hongzhang Huang; Yi Jin; Antonia Kolokythas; Anxun Wang; Yang Dai; David T W Wong; Xiaofeng Zhou
Journal:  Mol Carcinog       Date:  2011-12-07       Impact factor: 4.784

2.  Cervical node metastases in early squamous cell carcinoma of the floor of the mouth: predictive value of multiple histopathologic parameters.

Authors:  R W Nason; N B Castillo; K Sako; D P Shedd
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

3.  Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.

Authors:  Waseem Jerjes; Tahwinder Upile; Aviva Petrie; Andrew Riskalla; Zaid Hamdoon; Michael Vourvachis; Kostas Karavidas; Amrita Jay; Ann Sandison; Gareth J Thomas; Nicholas Kalavrezos; Colin Hopper
Journal:  Head Neck Oncol       Date:  2010-04-20

4.  Value of the supraomohyoid neck dissection with frozen section analysis as a staging procedure in the clinically negative neck in squamous cell carcinoma of the oral cavity.

Authors:  F J van den Hoogen; J J Manni
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

5.  Sentinel lymph node biopsy or elective neck dissection for patients with oral squamous cell carcinoma?

Authors:  Harri Keski-Säntti; Risto Kontio; Jyrki Törnwall; Ilmo Leivo; Sorjo Mätzke; Sinikka Suominen; Esa Leppänen; Timo Atula
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-02       Impact factor: 2.503

6.  Tumor thickness as an independent risk factor of early recurrence in oral cavity squamous cell carcinoma.

Authors:  Fábio Roberto Pinto; Leandro Luongo de Matos; Filipe Cavalcanti Palermo; Marco Aurélio Vamondes Kulcsar; Beatriz Godói Cavalheiro; Evandro Sobroza de Mello; Venâncio Avancini Ferreira Alves; Cláudio Roberto Cernea; Lenine Garcia Brandão
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-27       Impact factor: 2.503

Review 7.  Functional imaging in head and neck cancer.

Authors:  David I Kutler; Richard J Wong; Dennis H Kraus
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

8.  Perinerural, lymphovascular and depths of invasion in extrapolating nodal metastasis in oral cancer.

Authors:  Alkananda Sahoo; Swagatika Panda; Neeta Mohanty; Debkant Jena; Niranjan Mishra; Manas R Baisakh
Journal:  Clin Oral Investig       Date:  2019-05-28       Impact factor: 3.573

9.  Is there a role for neck dissection in T1 oral tongue squamous cell carcinoma? The UCLA experience.

Authors:  Kevin A Peng; Alan C Chu; Chi Lai; Tristan Grogan; David Elashoff; Elliot Abemayor; Maie A St John
Journal:  Am J Otolaryngol       Date:  2014-07-10       Impact factor: 1.808

10.  Are We Over-treating Neck in Buccal & Alveolo-buccal Cancers: Experience from a Tertiary Cancer Care Center.

Authors:  S V S Deo; N K Shukla; Deepak Jha; Paras Khanna; Archit Pandit; Sanjay Thulkar
Journal:  Indian J Surg Oncol       Date:  2012-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.